Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Shares Issued (2024 - 2025)

Rallybio's Shares Issued history spans 3 years, with the latest figure at -$10000.0 for Q3 2025.

  • For Q3 2025, Shares Issued rose 99.81% year-over-year to -$10000.0; the TTM value through Sep 2025 reached $63000.0, changed N/A, while the annual FY2024 figure was $5.4 million, 1816.67% up from the prior year.
  • Shares Issued for Q3 2025 was -$10000.0 at Rallybio, down from $5.4 million in the prior quarter.
  • Across five years, Shares Issued topped out at $5.4 million in Q4 2024 and bottomed at -$5.4 million in Q3 2024.
  • The 3-year median for Shares Issued is $31500.0 (2023), against an average of $15750.0.
  • The largest annual shift saw Shares Issued surged 7243.84% in 2024 before it surged 99.81% in 2025.
  • A 3-year view of Shares Issued shows it stood at $73000.0 in 2023, then soared by 7243.84% to $5.4 million in 2024, then tumbled by 100.19% to -$10000.0 in 2025.
  • Per Business Quant, the three most recent readings for RLYB's Shares Issued are -$10000.0 (Q3 2025), $5.4 million (Q4 2024), and -$5.4 million (Q3 2024).